Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | DPP4 | P27487 | 2/20 | 0.36 |
| ▸ | PDGFRB | P09619 | 1/20 | 0.34 |
| ▸ | PDGFRA | P16234 | 1/20 | 0.34 |
| ▸ | RPS6KB2 | Q9UBS0 | 1/20 | 0.31 |
| ▸ | CYP1A2 | P05177 | 1/20 | 0.31 |
| ▸ | CYP2E1 | P05181 | 1/20 | 0.31 |
| ▸ | CYP2D6 | P10635 | 1/20 | 0.31 |
| ▸ | CYP2A6 | P11509 | 1/20 | 0.31 |
| ▸ | CYP2B6 | P20813 | 1/20 | 0.31 |
| ▸ | CYP2C19 | P33261 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL799556 | 0.98 | DPP4 (0.38) | DPP4PDGFRBPDGFRARPS6KB2CYP1A2 | |
| SCHEMBL799548 | 0.90 | DPP4 (0.34) | DPP4PDGFRBPDGFRARPS6KB2CYP1A2 | |
| SCHEMBL799794 | 0.88 | DPP4 (0.36) | DPP4PDGFRBPDGFRACYP1A2CYP2E1 | |
| SCHEMBL799477 | 0.85 | DPP4 (0.38) | DPP4PDGFRBPDGFRACYP1A2CYP2E1 | |
| SCHEMBL799960 | 0.84 | DPP4 (0.40) | DPP4PDGFRBPDGFRACYP1A2CYP2E1 | |
| SCHEMBL14867609 | 0.76 | DPP4 (0.51) | DPP4PDGFRBPDGFRACYP1A2CYP2E1 | |
| SCHEMBL14871942 | 0.76 | APP (0.46) | DPP4PDGFRBPDGFRACYP1A2CYP2E1 | |
| SCHEMBL25701027 | 0.74 | RPS6KB2 (0.50) | RPS6KB2 | |
| SCHEMBL799488 | 0.73 | RPS6KB2 (0.34) | DPP4RPS6KB2 | |
| SCHEMBL799817 | 0.72 | RPS6KB2 (0.34) | DPP4RPS6KB2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-8663451-B2 | Linker, impedance biochip, and method of quantitatively detecting target analyte in fluid sample using the biochip | NATIONAL TAIWAN UNIVERSITY (TW) | 2014-03-04 | — | — | US | disclosed |
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | NATIONAL TAIWAN UNIVERSITY (TW) | 2012-03-22 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20120067742-A1 | LINKER, IMPEDANCE BIOCHIP, AND METHOD OF QUANTITATIVELY DETECTING TARGET ANALYTE IN FLUID SAMPLE USING THE BIOCHIP | EPCAM, CA13, CD44 | DPP4 4118/4885PDGFRB 4624/4885PDGFRA 4684/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.